Future of CPV Data Integration: Event Streaming, OPC UA, and Semantic Layers Future of CPV Data Integration: Event Streaming, OPC UA, and Semantic Layers Continued Process Verification (CPV) is an essential part of modern pharmaceutical manufacturing and drug development, ensuring that processes remain within predefined specifications throughout the product lifecycle. The integration of various data sources through innovative methods such as event streaming, OPC UA (Open Platform Communications Unified Architecture), and semantic layers is revolutionizing CPV, enhancing the ability to analyze and act on real-time data. This comprehensive guide will outline how these technologies contribute to building robust CPV data…

Using APIs and Connectors to Avoid Manual Data Wrangling for CPV Using APIs and Connectors to Avoid Manual Data Wrangling for CPV In the pharmaceutical industry, effective data management is crucial for ensuring compliance with regulatory requirements and maintaining the integrity of product quality. Continued Process Verification (CPV) serves as a critical element in the lifecycle performance management of pharmaceutical products. The integration of various data sources such as Historian, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), and Quality Management Systems (QMS) is essential for seamless data flow and analytics. This article explores the use of APIs and…

Security, Access Control and Part 11 Considerations for CPV Data Platforms Security, Access Control and Part 11 Considerations for CPV Data Platforms In the highly regulated pharmaceutical industry, the management of data integrity, security, and compliance is paramount, particularly with the advent of advanced technologies for Continued Process Verification (CPV). This regulatory explainer manual discusses essential considerations for CPV data platforms, emphasizing the integration of historian, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), and Quality Management Systems (QMS). It also addresses Part 11 compliance as mandated by the FDA, alongside contextual references pertinent to the EMA and MHRA…

Regulatory expectations for CPV driven revalidation decisions and justifications Regulatory expectations for CPV driven revalidation decisions and justifications Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) is a well-established framework within the pharmaceutical industry that is critical for ensuring the integrity, quality, and performance of drug manufacturing processes throughout their lifecycle. CPV is an integral part of FDA’s Guidance for Industry, specifically under the Quality by Design (QbD) paradigm, which emphasizes a proactive approach to drug quality management. In this framework, regulatory expectations dictate that organizations must continuously monitor process performance and product quality to identify any potential…

How to distinguish between common cause variation and special cause in CPV How to Distinguish Between Common Cause Variation and Special Cause in Continued Process Verification Continued Process Verification (CPV) enhances quality assurance and effective lifecycle performance management in pharmaceutical manufacturing. An intrinsic part of CPV involves distinguishing between common cause variation, which is inherent to a process, and special cause variation, which signals an external disturbance to the process. Accurately identifying these variations is critical for successful Quality Management Systems, especially in the context of responses such as Corrective and Preventive Actions (CAPA) and revalidation protocols. This article will…

Developing SOPs for CPV Signal Triage, Documentation and Decision Making Developing SOPs for CPV Signal Triage, Documentation and Decision Making Continued Process Verification (CPV) is a crucial aspect of pharmaceutical manufacturing, ensuring that processes remain within validated parameters and that product quality is maintained throughout the product lifecycle. For regulatory compliance and enhanced product quality, companies must effectively triage signals arising from CPV data, document deviations, and make informed decisions regarding Corrective and Preventive Actions (CAPA) and revalidation. This manual provides a comprehensive overview of developing Standard Operating Procedures (SOPs) to efficiently support these activities. Understanding the Role of CPV…

Risk based classification of CPV events into alert, action and revalidation levels Risk Based Classification of CPV Events into Alert, Action, and Revalidation Levels In the pharmaceutical industry, the effective management of continued process verification (CPV) events is essential for ensuring product quality and compliance with regulatory requirements. The classification of CPV events into alert, action, and revalidation levels serves as a critical framework for decision-making, enabling companies to proactively address deviations and implement necessary corrective actions. This article provides an in-depth examination of risk-based classification methodologies, the interplay between CPV triggers for corrective and preventive actions (CAPA), and how…

Linking CPV Out of Trend Signals to Deviation, Investigation and CAPA Workflows Linking CPV Out of Trend Signals to Deviation, Investigation and CAPA Workflows The landscape of pharmaceutical manufacturing has evolved significantly in recent years, especially concerning the implementation of Continued Process Verification (CPV) as a cornerstone of quality assurance. CPV is critical for demonstrating that a process remains in a state of control throughout its lifecycle. In the context of FDA regulations (Title 21 of the Code of Federal Regulations – 21 CFR Part 211.110), the effective identification of out of trend (OOT) signals is paramount for efficient corrective…

Case Studies Where CPV Triggers Led to Early Issue Detection and Avoidance Case Studies Where CPV Triggers Led to Early Issue Detection and Avoidance Continued Process Verification (CPV) has emerged as a crucial element in managing the lifecycle performance of pharmaceutical manufacturing processes. Through systematic monitoring and data analysis, CPV aims to detect and mitigate issues before they escalate into significant quality failures or regulatory non-compliance. This article explores case studies where CPV triggers have facilitated early issue detection and avoidance, focusing on effective risk-based event classification, the implementation of digital alert tools, and the strategic use of CAPA (Corrective…

Common pitfalls where CPV signals are ignored or under reacted to Common pitfalls where CPV signals are ignored or under reacted to Continued Process Verification (CPV) is a vital component in ensuring the consistent quality and compliance of pharmaceutical products throughout their lifecycle. The regulatory frameworks established by the FDA, EMA, and MHRA necessitate that organizations develop a robust framework for monitoring and responding to CPV signals. However, various pitfalls exist that can lead to the underreaction or total disregard for these signals, which can have significant implications for product quality and patient safety. This article provides an in-depth look…